ARTN and cancer: Altogether, the data indicate that miR-34a-less EV drives a sensory axonogenic switch and sensory nerve reprogramming to the adrenergic nerve.225 In the TME, the joint effect of soluble neurotrophic factors and pro-axonogenic EVs can lead to pro-tumor innervation during cancer progression, establishing a new pharmacologically modulable paradigm.223